Bidirectional disruption of GNAS transcripts causes broad methylation defects in pseudohypoparathyroidism type 1B
Proceedings of the National Academy of Sciences · 22.04.2025 · 122 (16)
DOI: 10.1073/pnas.2423271122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 18.04.2025. Verfasst von Yorihiro Iwasaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114. Hauptthemen laut MEDLINE: Pseudohypoparathyroidism, DNA Methylation, Chromogranins, GTP-Binding Protein alpha Subunits, Gs. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIDDK NIH HHS, Cell Science Research Foundation.
Abstract (Originalsprache)
Pseudohypoparathyroidism type 1B (PHP1B) is a multihormone resistance disorder caused by aberrant GNAS methylation. Characteristic epigenetic changes at GNAS differentially methylated regions (DMRs), i.e., NESP, AS1, AS2, XL, and A/B, are associated with specific structural defects in different autosomal dominant PHP1B (AD-PHP1B) subtypes. However, mechanisms underlying abnormal GNAS methylation remain incompletely defined, largely because viable PHP1B mouse models are lacking. Using lymphoblastoid cells and induced pluripotent stem cells, we show that various GNAS methylation patterns in PHP1B reflect differential disruption of sense and antisense GNAS transcripts. In cases with broad GNAS methylation changes, loss of the maternal, sense-transcribed exon H/AS region impairs methylation of the AS1 DMR, which results in biallelic expression of an antisense transcript, GNAS-AS1 , and NESP hypermethylation. In contrast, cases with normal AS1 methylation, including STX16 deletions, show monoallelic GNAS-AS1 expression and normal NESP methylation. The roles of these GNAS transcripts were confirmed by a retrotransposon in GNAS-AS1 intron 1, identified in an AD-PHP1B family. This insertion impaired exon H/AS transcription when located on the maternal allele, thus preventing the complete establishment of methylation at all maternal GNAS DMRs, leading to biallelic GNAS-AS1 transcription. However, maternal GNAS-AS1 transcription was profoundly attenuated, thus allowing only a small gain-of-methylation at NESP. Likewise, on the paternal allele, the retrotransposon attenuated GNAS-AS1 transcription, thus preventing complete NESP methylation. Our findings support a model of bidirectional transcription-mediated regulation of methylation at GNAS DMRs and will help to refine systematic approaches for establishing molecular defects underlying different PHP1B subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
- Division of Endocrinology, Metabolism & Nephrology, Tazuke Kofukai Medical Research Institute, Kitano Hospital, Osaka 5308480, Japan.
- Center for Endocrinology, Diabetes, and Metabolism, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA 90027.
- Department of Pediatrics, Division of Pediatric Nephrology, University of California, Los Angeles, Geffen School of Medicine, Los Angeles, CA 90095.
- Université Paris-Saclay, INSERM, Physiologie et Physiopathologie Endocriniennes, Le Kremlin-Bicêtre 94276, France.
- Assistance Publique-Hôpitaux de Paris, Centre de Référence des Maladies du Métabolisme du Calcium et du Phosphate and Service d'Endocrinologie d'Endocrinologie et Diabète de l'enfant, Hôpital Bicêtre, Le Kremlin-Bicêtre…
ORCID-Profile: Yorihiro Iwasaki, Anna Ryabets-Lienhard, Agnès Linglart, Danny E Miller, Murat Bastepe, Harald Jüppner
Förderung
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIDDK NIH HHS
- Cell Science Research Foundation
- International Medical Research Foundation
- HHS | National Institutes of Health (NIH)
- NIH HHS
- Uehara Memorial Foundation (UMF)
- Japan Society for the Promotion of Science London (JSPS)
Zitieren
APA
Iwasaki, Y., Reyes, M., Ryabets-Lienhard, A., Gales, B., Linglart, A., Miller, D. E., Salusky, I. B., Bastepe, M., & Jüppner, H. (2025). Bidirectional disruption of GNAS transcripts causes broad methylation defects in pseudohypoparathyroidism type 1B. Proceedings of the National Academy of Sciences, 122(16). https://doi.org/10.1073/pnas.2423271122
Vancouver
Iwasaki Y, Reyes M, Ryabets-Lienhard A, Gales B, Linglart A, Miller DE, et al. Bidirectional disruption of GNAS transcripts causes broad methylation defects in pseudohypoparathyroidism type 1B. Proceedings of the National Academy of Sciences. 2025;122(16). doi:10.1073/pnas.2423271122
BibTeX
@article{Iwasaki2025,
author = {Iwasaki, Yorihiro and Reyes, Monica and Ryabets-Lienhard, Anna and Gales, Barbara and Linglart, Agnès and Miller, Danny E and Salusky, Isidro B and Bastepe, Murat and Jüppner, Harald},
title = {Bidirectional disruption of GNAS transcripts causes broad methylation defects in pseudohypoparathyroidism type 1B},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {16},
doi = {10.1073/pnas.2423271122}
}
EUVIMED